Table 1.
Demographics and laboratory findings in patients with acute pancreatitis
| Variables | (1) MAP (n=197) | (2) MSAP (n=76) | (3) SAP (n=86) | p Value |
||
|---|---|---|---|---|---|---|
| All groups | 1 vs 2 | 2 vs 3 | ||||
| Age (years) | 51.43±16.00 | 48.47±13.28 | 50.69±14.61 | 0.352 | 0.446 | 1.000 |
| Male (%) | 108 (54.8%) | 41 (53.9%) | 49 (57.0%) | 0.919 | 0.896 | 0.699 |
| Aetiology (1/2/3/4)% | 52%/12%/11%/25% | 51%/16%/13%/20% | 47%/15%/14%/24% | 0.875 | 0.664 | 0.892 |
| WCC (×109/L) | 11.5 (3.1–32.0) | 14.1 (4.5–36.8) | 16.05 (5.9–38.4) | <0.001 | <0.001 | 0.278 |
| Lymphocyte (×109/L) | 1.1 (0.2–9.4) | 1.0 (0.2–2.6) | 0.80 (0.2–2.9) | <0.001 | 0.004 | 0.089 |
| Platelet (×109/L) | 202 (21–502) | 193 (58–548) | 163 (27–540) | 0.004 | 0.376 | 0.046 |
| Albumin (g/L) | 38.29±5.07 | 34.38±6.39 | 29.99±5.35 | <0.001 | <0.001 | <0.001 |
| CRP (mg/L) | 53.9 (0.7–386) | 133.6 (3.2–436.5) | 196.1 (27.1–426.7) | <0.001 | <0.001 | <0.001 |
| Amylase (U/L) | 398 (13–5191) | 222 (27–3845) | 581 (16–2377) | 0.141 | 0.083 | 0.056 |
| RDW (%) | 12.8 (11.4–19.2) | 13.0 (11.3–16.3) | 13.7 (11.7–23.6) | <0.001 | 0.013 | 0.014 |
| NLR | 8.46 (1.33–55) | 14.60 (1.73–60) | 19.65 (3.57–53.67) | <0.001 | <0.001 | 0.020 |
| LMR | 1.88 (0.28–13.33) | 1.03 (0.29–5.33) | 1.14 (0.22–6.32) | <0.001 | <0.001 | 0.883 |
| PNI | 44.53±6.63 | 39.36±6.71 | 34.55±6.02 | <0.001 | <0.001 | <0.001 |
| Mortality (%) | 0 (0%) | 0 (0%) | 31 (36.0%) | <0.001 | – | <0.001 |
Continuous variables are presented as mean±SD or median (range).
Aetiology (1/2/3/4)%, 1, 2, 3 and 4 represent gallstone, alcohol, hypertriglyceridaemia and other aetiologies, respectively.
1 vs 2, MAP group versus MSAP group; 2 vs 3, MSAP group versus SAP group.
CRP, C reactive protein; LMR, lymphocyte–monocyte ratio; MAP, mild acute pancreatitis; MSAP, moderately severe acute pancreatitis; NLR, neutrophil–lymphocyte ratio; PNI, prognostic nutritional index; RDW, red cell distribution width; SAP, severe acute pancreatitis; WCC, white cell count.